Royal Bank of Canada
IART icon

Royal Bank of Canada’s Integra LifeSciences IART Stock Holding History

Royal Bank of Canada’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-489
Closed -$10K – 5995
2013
Q4 		$10K Hold
489
– – ﹤0.01% 5450
2013
Q3 		$8K Buy
+489
New +$7.85K ﹤0.01% 5488

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royal Bank of Canada's IART Position: Q1 2026 in Review

Royal Bank of Canada reduced its Integra LifeSciences (IART) stake by 35% in Q1 2026, selling an estimated $40.2K and leaving 6,796 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #5359.

Royal Bank of Canada first reported a position in IART in Q2 2013 and has held it in 52 quarters since. The position peaked at $58.5M in Q2 2017. 202 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Royal Bank of Canada held 6,796 shares of Integra LifeSciences worth $64K as of Q1 2026.
  • Royal Bank of Canada sold 3,662 Integra LifeSciences shares in Q1 2026, an estimated $40.2K.
  • Integra LifeSciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5359 holding.
  • Royal Bank of Canada first reported a position in Integra LifeSciences in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Integra LifeSciences position peaked at $58.5M in Q2 2017.
  • 202 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.